# Host factors and viral determinants mediating flavivirus NS1 tissue-specific endothelial dysfunction and vascular leak

> **NIH NIH R01** · UNIVERSITY OF CALIFORNIA BERKELEY · 2023 · $670,954

## Abstract

Host factors and viral determinants mediating flavivirus NS1 tissue-specific endothelial dysfunction and
vascular leak
ABSTRACT
The flavivirus (FV) genus contains medically important mosquito-borne human pathogens that cause a major
global disease burden. While dengue (DENV), yellow fever (YFV), and Zika (ZIKV) viruses are systemic, and
West Nile (WNV), Japanese encephalitis (JEV), and Zika viruses cause neurotropic infections, each FV can
cause severe disease characterized in part by endothelial barrier dysfunction – the most classic example being
vascular leak in severe dengue. This may result from overproduction of vasoactive cytokines as well as viral
factors. The highly conserved FV non-structural protein 1 (NS1) is secreted from infected cells and circulates in
the blood of infected humans. We and others have shown that FV NS1 can trigger endothelial barrier disruption
in vitro and vascular leak in mice, independently from virus infection. In our current R01, we showed that endo-
cytosis of FV NS1 into endothelial cells (ECs) followed by activation of key enzymes such as cathepsin L and
heparanase leads to disruption of the endothelial glycocalyx layer (EGL) as well as mislocalization of intercellular
junction proteins, both critical for maintaining endothelial barrier integrity. Interestingly, we found that FV NS1
proteins display exquisite tissue tropism, triggering EC dysfunction in vitro and in vivo in a manner reflecting
tissue tropism and disease manifestations of each virus. While FV NS1 tissue tropism was determined by
differential EC binding and internalization, downstream activation of key enzymes and signaling pathways
required for pathogenesis appear to be conserved across FVs. However, host factors, viral determinants, and
mechanisms mediating these processes are unknown. We hypothesize that distinct host factors on tissue-
specific ECs mediate FV NS1 cell binding and internalization, leading to endothelial barrier dysfunction, virus
dissemination, and different FV disease manifestations. In contrast, once a FV NS1 protein is internalized, we
hypothesize that downstream steps of EC dysfunction are comparable – thus pointing the way to a pan-FV
intervention. Here, we expand our previous work by identifying and characterizing host glycans, proteins,
and NS1 determinants required for tissue-specific cell binding and internalization of NS1 in human ECs, mouse
models, and clinical samples. We also define common mechanisms by which FV NS1 proteins trigger
pathology. In Aim 1, we will identify and characterize host glycans and FV NS1 determinants required for differ-
ential binding to tissue-specific ECs. In Aim 2, we will identify proteinaceous NS1 receptors required to initiate
EC dysfunction and define mechanisms by which FV NS1 proteins mediate disruption of the EGL and intercellular
junctions in tissue-specific ECs in vitro and in vivo. Aim 3 investigates the impact of FV NS1-mediated endothelial
dysfunction on FV dissemination a...

## Key facts

- **NIH application ID:** 10610896
- **Project number:** 5R01AI168003-02
- **Recipient organization:** UNIVERSITY OF CALIFORNIA BERKELEY
- **Principal Investigator:** Eva Harris
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2023
- **Award amount:** $670,954
- **Award type:** 5
- **Project period:** 2022-04-18 → 2027-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10610896

## Citation

> US National Institutes of Health, RePORTER application 10610896, Host factors and viral determinants mediating flavivirus NS1 tissue-specific endothelial dysfunction and vascular leak (5R01AI168003-02). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10610896. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*
